Toggle Main Menu Toggle Search

ePrints

First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors

Lookup NU author(s): Professor Ruth Plummer, Dr Christopher Jones, Lynsey Robson, Professor Alan Calvert

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Plummer R, Middleton M, Wilson R, Jones C, Evans J, Robson L, Steinfeldt H, Kaufman R, Reich S, Calvert AH

Publication type: Article

Journal: Journal of Clinical Oncology

Year: 2005

Volume: 23

Issue: 16 Supplement 1

Pages: 208 no. 3065

ISSN (print): 0732-183X

ISSN (electronic): 1527-7755

URL: http://meeting.ascopubs.org/cgi/content/abstract/23/16_suppl/3065

Notes: First presented at the 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, USA. 13-17 May, 2005.


Actions

    Link to this publication


Share